Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries.

Among patients and physicians, the highest levels of knowledge were on the most important risks, as expected. The Prescriber Guide and Patient Alert Card were found to be useful sources of information.